Acadian Asset Management
XGN icon

Acadian Asset Management’s Exagen XGN Stock Holding History

Acadian Asset Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
310,084
-379,030
-55% -$1.43M ﹤0.01% 1158
2026
Q1 		$2.06M Buy
689,114
+274,666
+66% +$1.06M ﹤0.01% 951
2025
Q4 		$2.52M Buy
414,448
+300,618
+264% +$2.74M ﹤0.01% 852
2025
Q3 		$1.25M Buy
113,830
+101,231
+803% +$897K ﹤0.01% 1001
2025
Q2 		$87K Buy
12,599
+5,615
+80% +$34.1K ﹤0.01% 1424
2025
Q1 		$25K Buy
+6,984
New +$26.4K ﹤0.01% 1514

Other funds holding XGN

NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Acadian Asset Management's XGN Position: Q2 2026 in Review

Acadian Asset Management reduced its Exagen (XGN) stake by 55% in Q2 2026, selling an estimated $1.43M and leaving 310,084 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Acadian Asset Management first reported a position in XGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.52M in Q4 2025. 52 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Acadian Asset Management held 310,084 shares of Exagen worth $1.44M as of Q2 2026.
  • Acadian Asset Management sold 379,030 Exagen shares in Q2 2026, an estimated $1.43M.
  • Exagen made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1158 holding.
  • Acadian Asset Management first reported a position in Exagen in Q1 2025 and has held it in 6 quarters since.
  • Acadian Asset Management's Exagen position peaked at $2.52M in Q4 2025.
  • 52 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.